Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients
Authors:
- 6 August 2010
- journal article
- research article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 12 (5) , 489-497
Abstract
Anxiety and fear are often associated with chronic conditions such as cancer. This paper targets the cost-effectiveness analysis of a cognitive-behavioral group therapy (CBT) in comparison to a client-centered, supportive-experiential group therapy (SET) in cancer patients with dysfunctional fear of progression. An incremental cost-effectiveness analysis was performed using data from a randomized controlled trial among cancer patients receiving inpatient rehabilitation. The means, 95% confidence intervals [95% CI], incremental cost-effectiveness graphic and acceptability curve were obtained from 1,000 bootstrap replications. A total of 174 patients were included in the economic evaluation. The estimated means [95% CI] of direct costs and reduction of fear of progression were €9,045.03 [6,359.07; 12,091.87] and 1.41 [0.93; 1.92] for patients in the SET and €6,682.78 [4,998.09; 8,440.95] and 1.44 [1.02; 1.09] for patients in the CBT. The incremental cost-effectiveness ratio [95% CI] amounts to minus €78,741.66 [−154,987.20; 110,486.32] for an additional unit of effect. Given the acceptability curve, there is a 92.4% chance that the CBT, compared with the SET, is cost-effective without the need of additional costs to payers. Our main result is the superior cost-effectiveness of the cognitive-behavioral intervention program in comparison to the non-directive encounter group for our sample of cancer patients with high levels of anxiety.Keywords
This publication has 26 references indexed in Scilit:
- Evaluation of two group therapies to reduce fear of progression in cancer patientsSupportive Care in Cancer, 2009
- Converting the SF-12 into the EQ-5DPharmacoEconomics, 2009
- Cost of anxiety disorders in EuropeEuropean Journal of Neurology, 2005
- Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questionsHealth Economics, 2004
- Systematic Review of Psychological Therapies for Cancer Patients: Overview and Recommendations for Future ResearchJNCI: Journal of the National Cancer Institute, 2002
- Effect of Group Therapy for Breast Cancer on Healthcare UtilizationCancer Practice, 2001
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000
- Methoden zur Kostenerfassungim Rahmen der ökonomischen Evaluation einer Rehabilitations-maßnahme bei chronischen AtemwegserkrankungenPneumologie, 2000
- The impact of psychological interventions on medical cost offset: A meta-analytic review.Clinical Psychology: Science and Practice, 1999
- Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments.Health Psychology, 1995